Shin Eun, Kim Ji Hoon, Yu Eunsil
Department of Pathology, Seoul National University Bundang Hospital, Seongnam, Korea.
Korean J Pathol. 2013 Feb;47(1):21-7. doi: 10.4132/KoreanJPathol.2013.47.1.21. Epub 2013 Feb 25.
We summarize our experience in the pathological diagnosis of late complications of liver transplantation (LT) to better understand the causes of late allograft dysfunction in a population mostly composed of patients with hepatitis B virus (HBV) infection.
We reviewed 361 post-transplant liver biopsies from 174 patients who underwent LT and first presented with liver function abnormalities 3 months post-procedure. The underlying diseases included HBV-associated liver disease (77%), toxic or alcoholic liver disease (10.3%), hepatitis C virus (HCV)-associated liver disease (8.6%), primary biliary cirrhosis (1.2%), primary sclerosing cholangitis (1.2%), and metabolic disease (1.7%).
The three most common late complications were acute rejection (32.5%), recurrent disease (19.1%), and biliary complication (17.1%). Patients who underwent LT for HBV infection or for drug- or alcohol-related liver disease had a lower incidence of recurring disease than those who underwent transplantation for HCV infection. During post-transplantation months 3-12, acute rejection was the most common cause of allograft dysfunction and recurring disease was the leading cause for allograft dysfunction (p=0.039). The two primary causes of late allograft dysfunction have overlapping histological features, although acute rejection more frequently showed bile duct damage and vascular endothelialitis than recurring HBV infection, and recurring HBV infection had more frequent lobular activity and piecemeal necrosis.
The causes of late liver allograft dysfunction are closely associated with the original liver diseases and the period after LT. Careful attention is required for differential diagnosis between acute rejection and recurrent HBV.
我们总结了肝移植(LT)晚期并发症的病理诊断经验,以便更好地了解在主要由乙型肝炎病毒(HBV)感染患者组成的人群中晚期移植物功能障碍的原因。
我们回顾了174例行LT患者的361份移植后肝活检,这些患者术后3个月首次出现肝功能异常。基础疾病包括HBV相关肝病(77%)、中毒性或酒精性肝病(10.3%)、丙型肝炎病毒(HCV)相关肝病(8.6%)、原发性胆汁性肝硬化(1.2%)、原发性硬化性胆管炎(1.2%)和代谢性疾病(1.7%)。
三种最常见的晚期并发症是急性排斥反应(32.5%)、复发性疾病(19.1%)和胆道并发症(17.1%)。因HBV感染或药物或酒精相关肝病接受LT的患者复发性疾病的发生率低于因HCV感染接受移植的患者。在移植后3至12个月期间,急性排斥反应是移植物功能障碍最常见的原因,而复发性疾病是移植物功能障碍的主要原因(p = 0.039)。晚期移植物功能障碍的两个主要原因具有重叠的组织学特征,尽管急性排斥反应比复发性HBV感染更常表现为胆管损伤和血管内皮炎,而复发性HBV感染具有更频繁的小叶活动和桥接坏死。
晚期肝移植物功能障碍的原因与原肝脏疾病和LT后的时期密切相关。急性排斥反应和复发性HBV之间的鉴别诊断需要仔细关注。